| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/13/2008 | EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1044189B1 Aryl fused azapolycyclic compounds |
| 02/13/2008 | CN101124232A 烟碱乙酰胆碱受体的配体 Nicotinic acetylcholine receptor ligands |
| 02/13/2008 | CN100368422C L-nucleic acid derivatives and processes for synthesis thereof |
| 02/13/2008 | CN100368397C Prodrugs to d-prolines |
| 02/12/2008 | US7329747 Synthesis of olanzapine and intermediates thereof |
| 02/12/2008 | US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction |
| 02/07/2008 | WO2007136300A3 Substituted indoles and a method for the production and use thereof |
| 02/06/2008 | CN100366624C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles |
| 02/06/2008 | CN100366251C Organic compounds |
| 02/05/2008 | US7326784 Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
| 02/05/2008 | US7326718 8-Substituted imidazopyridines |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326703 (1,10B-Dihydro-2-(aminocarbonyl-phenyl)-5H-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors |
| 02/05/2008 | US7326702 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 02/05/2008 | US7326701 Lactam compounds and pharmaceutical use thereof |
| 01/31/2008 | WO2008014222A1 Crystalline forms of rapamycin analogs |
| 01/31/2008 | WO2007123892A3 Raf inhibitors and their uses |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027073 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 01/31/2008 | US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio) |
| 01/31/2008 | US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | CA2658896A1 Crystalline forms of rapamycin analogs |
| 01/30/2008 | EP1882689A1 Tri- or tetra-substituted-3-aminopyrrolidine derivatives |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881989A1 Thienopyrroles as antiviral agents |
| 01/30/2008 | EP1881825A2 Hiv integrase inhibitors |
| 01/30/2008 | CN101115761A Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 01/30/2008 | CN101115759A Cci-779 polymorph and use thereof |
| 01/30/2008 | CN101115758A Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same |
| 01/30/2008 | CN101115753A Bridged ring nk1 antagonists |
| 01/29/2008 | US7323569 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine. |
| 01/29/2008 | US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/24/2008 | WO2008011110A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 01/24/2008 | WO2008009700A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 01/24/2008 | WO2008009122A1 Acrylamide derivatives as fab i inhibitors |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | US20080021211 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 01/24/2008 | US20080021047 C-Purine Nucleoside Analogs As Inhibitors Of Rna-Dependent Rna Viral Polymerase |
| 01/24/2008 | US20080016674 Method And Installation Means For Installing An Electrical Machine |
| 01/24/2008 | CA2658506A1 Acrymalide derivatives as fab 1 inhibitors |
| 01/24/2008 | CA2658261A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 01/24/2008 | CA2658190A1 Di-amino-substituted heterocyclic compounds and methods of use |
| 01/23/2008 | EP1879904A1 4" amino linked macrolides useful for the treatment of microbial infections |
| 01/23/2008 | EP1725232B1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/22/2008 | US7321040 MAP (mitogen-activated protein) kinase inhibitors; osteoarthritis, rheumatoid arthritis, anticarcinogenic or antiischemic agents; reperfusion injuries, strokes or heart attack; autoimmune, skin, cardiovascular, brain, bone, neurodegenerative, respiratory system and nervous system disorders |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/17/2008 | WO2008008480A2 Nitroheteroaryl-containing rifamycin derivatives |
| 01/17/2008 | WO2008008432A2 Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
| 01/17/2008 | WO2008007661A1 Tricyclic heterocyclic compound and use thereof |
| 01/17/2008 | WO2008007210A2 Nitrogenous n-substituted 4-spiro-heterocyclic 2, 2 -dimethylchromane derivatives |
| 01/17/2008 | WO2007106587A3 Process for purifying tacrolimus |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080014614 Labeling of rapamycin using rapamycin-specific methylases |
| 01/17/2008 | CA2654583A1 Mtki quinazoline derivatives |
| 01/16/2008 | EP1877517A2 Luminous compound containing lanthanide ion |
| 01/16/2008 | EP1877399A1 Triazole derivatives as vasopressin antagonists |
| 01/16/2008 | EP1697383A4 Process for the purification of macrolides |
| 01/16/2008 | EP1625126B1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1354020B1 Novel red fluorescent material and organic electroluminescent device containing same |
| 01/16/2008 | CN101106998A Mitotic kinesin inhibitors |
| 01/16/2008 | CN100361982C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 01/10/2008 | WO2008006097A2 Covalent modification of metal surfaces |
| 01/10/2008 | WO2008003424A1 Substituted benzoxepino-isoxazoles and use thereof |
| 01/10/2008 | WO2007104652A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/10/2008 | US20080009483 3-{[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]methyl}-N-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-4-hydroxycyclopentanecarboxamide; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/10/2008 | US20080006798 chromenes, spiroindoline naphthoxazines linked to polysiloxanes; living polymerization; reduced fade half life; optical lenses, face shields, goggles, visors, camera lenses, windows, automotive windshields, aircraft and automotive transparencies, plastic films and sheets |
| 01/10/2008 | DE102006031176A1 Substituierte Benzoxepino-isoxazole und ihre Verwendung Substituted benzoxepino-isoxazoles and their use |
| 01/10/2008 | CA2656633A1 Substituted benzoxepinoisoxazoles and the use thereof |
| 01/09/2008 | EP1874783A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 01/09/2008 | EP1874782A1 Oxazolidinone derivatives as antimicrobials |
| 01/09/2008 | EP1874768A2 Inhibitors of akt activity |
| 01/09/2008 | EP1874741A1 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 01/09/2008 | EP1625117B1 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indictor in the detection of microorganisms with peptidase activity |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | CN101103029A 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
| 01/09/2008 | CN101103000A Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production |
| 01/08/2008 | US7317021 Cancers that express nitric oxide synthase; 2-[2-(2-Amino-4-methylpyridin-6-yl)ethyl]-3H-imidazo[4,5-b]pyridine |
| 01/08/2008 | US7317005 Cyclic oligopeptide; hypotensive agents; congestive heart failure, antiischemic agents, cirrhosis, kidney failure, strokes; thrombosis |
| 01/08/2008 | CA2334298C Neuropeptide y5 receptor antagonists |
| 01/03/2008 | WO2008001182A1 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 01/03/2008 | WO2008000646A1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 01/03/2008 | WO2008000645A1 Tetrazole-substituted arylamides |
| 01/03/2008 | WO2008000469A2 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
| 01/03/2008 | WO2007096703A3 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 01/03/2008 | US20080004334 Thiolactones |
| 01/03/2008 | US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period |
| 01/03/2008 | US20080004253 Thiazolopyrimidine modulators of TRPV1 |
| 01/03/2008 | CA2654915A1 Tetrazole-substituted arylamides |
| 01/03/2008 | CA2654394A1 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 01/02/2008 | EP1872785A1 pharmaceutical composition comprising condensed indole compound |
| 01/02/2008 | EP1871778A1 Fermentation broth extraction of k-252a |
| 01/02/2008 | EP1871777A1 (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors |